Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.
about
Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsPrognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysisPrognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysisHilar cholangiocarcinoma: diagnosis, treatment options, and management.High expression of L-type amino acid transporter 1 as a prognostic marker in bile duct adenocarcinomasPrognostic significance of the neutrophil-to-lymphocyte ratio in primary liver cancer: a meta-analysis.Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent ResectionPrognostic factors and long-term outcomes of hilar cholangiocarcinoma: A single-institution experience in China.Clinical value of preoperative serum CA 19-9 and CA 125 levels in predicting the resectability of hilar cholangiocarcinoma.Predictors of long term survival after hepatic resection for hilar cholangiocarcinoma: A retrospective study of 5-year survivors.Prognostic Significance of Neutrophil to Lymphocyte Ratio in Oncologic Outcomes of Cholangiocarcinoma: A Meta-analysis.Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy is useful to predict a more accurate prognosis of advanced biliary tract cancer.Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.Multimodal treatment strategies for advanced hilar cholangiocarcinoma.Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cureUse of gemcitabine-platinum in Indian patients with advanced gall bladder cancer.Derived neutrophil lymphocyte ratio may predict benefit from cisplatin in the advanced biliary cancer: the ABC-02 and BT-22 studies.Neutrophil-lymphocyte ratio predicts survival in patients with advanced cholangiocarcinoma on chemotherapy.Can preoperative and postoperative CA19-9 levels predict survival and early recurrence in patients with resectable hilar cholangiocarcinoma?Feasibility and efficacy of gemcitabine plus cisplatin combination therapy after curative resection for biliary tract cancer.The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection.Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma.The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: Systematic review and meta-analysis.The pretreatment neutrophil-lymphocyte ratio may predict prognosis of patients with liver cancer: A systematic review and meta-analysis.The pretransplant neutrophil-lymphocyte ratio as a new prognostic predictor after liver transplantation for hepatocellular cancer: a systematic review and meta-analysis.Effect of preoperative cholangitis on prognosis of patients with hilar cholangiocarcinoma: A systematic review and meta-analysisThe clinicopathological factors associated with prognosis of patients with resectable perihilar cholangiocarcinoma: A systematic review and meta-analysisResection for Klatskin tumors: technical complexities and resultsPattern of the First Recurrence Has No Impact on Long-Term Survival after Curative Intent Surgery for Perihilar Cholangiocarcinomas
P2860
Q27009534-82F228DD-A478-4F6F-9B4B-B63F874D5E6BQ27022482-978CAC24-DFB6-4FBC-8029-D28B72152771Q33829684-3CB09EE7-04F7-452F-96EA-BFE9B76585AAQ34661001-7EB7FCEA-CE04-4ACC-8F85-FC45D410135CQ34998503-F34EC0AC-D114-4F55-A602-6D8685F41FB6Q35161694-351ED87C-C8D1-49CF-B5AC-584F75B436D5Q36529570-2D5EC9A8-2766-4BA2-86AE-D9C608C5EA82Q36621535-37392CA6-B17C-4007-9B10-2C548CCF4DA1Q36853409-96ADA489-8F8F-419E-9AB4-14BBDE284D1FQ37035120-0D7E36F5-FBB0-4ACC-B7B6-30A0A4970235Q37303732-774D732E-B331-4CF3-AEED-E0F347226B82Q37709278-A2B37AA2-5556-473F-B1A4-1A9F785C4319Q38212836-981FE5ED-12FC-4180-8D83-176004862817Q38222988-F249D945-A2D7-44C2-975B-DB8B21597BF7Q38265727-88C3E522-89D5-4277-8F43-500C1491CECDQ39022553-B6BE3909-10FD-4634-AF54-230989203CB5Q40875509-5DB03D04-2FFB-480F-9E89-B7A60BBCC145Q41002124-F4AEE6D0-B1B2-440C-A6A9-2C6228400319Q41233354-FCD96907-8D9F-4497-A308-C7D03C268653Q41521606-B29AE7D2-B3A5-43DA-B65E-EA174B028C06Q44965723-5A9B474B-CAA5-422B-80E3-DC04B4B6ECE4Q47160677-8B4D6E73-D314-478F-841A-C9E77BFECFC0Q47338550-CD2810AC-49F2-42C2-93D1-8665D3498AAAQ48350251-82A51264-A81A-441A-8493-6A44F1AFCF57Q50072148-0F436F01-83F5-4073-9DF4-17024D0281E9Q57113419-D6FD46E1-4D6B-4500-ACA5-4A3A61865154Q57113431-2D4B43C4-8516-4B4D-9EC1-73F53AD92473Q58554189-049DADB0-33D5-4549-A9B3-B47447E054DDQ58792818-ED619E1F-6D4E-4454-B5A0-83E33FEF8561
P2860
Resection for hilar cholangiocarcinoma: analysis of prognostic factors and the impact of systemic inflammation on long-term outcome.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Resection for hilar cholangioc ...... ammation on long-term outcome.
@en
Resection for hilar cholangioc ...... ammation on long-term outcome.
@nl
type
label
Resection for hilar cholangioc ...... ammation on long-term outcome.
@en
Resection for hilar cholangioc ...... ammation on long-term outcome.
@nl
prefLabel
Resection for hilar cholangioc ...... ammation on long-term outcome.
@en
Resection for hilar cholangioc ...... ammation on long-term outcome.
@nl
P2093
P2860
P1476
Resection for hilar cholangioc ...... ammation on long-term outcome.
@en
P2093
Dragos Chirita
Irinel Popescu
Mihnea Ionescu
Traian Dumitrascu
P2860
P2888
P304
P356
10.1007/S11605-013-2144-2
P577
2013-01-15T00:00:00Z